Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes

Philippe Gautret (1, 2) , van Thuan Hoang (1, 2) , Jean-Christophe Lagier (2, 3) , Didier Raoult (2, 3)

1 VITROME - Vecteurs - Infections tropicales et méditerranéennes
2 IHU Marseille - Institut Hospitalier Universitaire Méditerranée Infection
3 MEPHI - Microbes évolution phylogénie et infections

Domaines: Bactériologie; Virologie; Parasitologie; Cardiologie et système cardiovasculaire; Maladies émergentes; Maladies infectieuses

Philippe Gautret, van Thuan Hoang, Jean-Christophe Lagier, Didier Raoult. Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes. International Journal of Antimicrobial Agents, 2021, 57 (1), pp.106239. ⟨10.1016/j.ijantimicag.2020.106239⟩. ⟨hal-03216101⟩